Manila Bulletin
DOH: 500 patients joining the WHO's Solidarity trial; identifies 20 participating hospitals
The Department of Health (DOH) has announced that 500 patients from 20 hospitals nationwide will participate in the WHO's Solidarity trial to find effective treatments for COVID-19.
The DOH has communicated with the WHO regarding the list of participating hospitals, the number of patients, and the required drugs for the trial.
The WHO has assured the DOH that it will soon ship the necessary drugs for the trial.
The DOH plans to use existing drug stocks in the Philippines while waiting for the WHO's shipment to start the trial immediately.
The Solidarity trial involves testing four potential therapies: remdesivir, chloroquine/hydroxychloroquine, and lopinavir/ritonavir with or without interferon beta-1a.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The Department of Health (DOH) is considering participating in the World Health Organization's (WHO) Solidarity Trial for COVID-19 vaccines.
Read more →
The Department of Health (DOH) announced that 500 COVID-19 patients in the Philippines will undergo clinical trials for potential drugs, but they must meet specific qualifications to be included.
Read more →
The Food and Drug Administration (FDA) clarified that Carrimycin, a Chinese drug reportedly used by AFP Chief of Staff General Felimon Santos Jr. for his COVID-19 recovery, is not part of the Philippines' official clinical trials.
Read more →